Aspartes Pharmaceuticals, Inc.

This early-stage study aims to understand how the body absorbs and processes two new fast-dissolving tablet versions of a migraine drug called flunarizine. It will compare these new tablets to the standard pill already available in some countries. The study involves 12 healthy ad…